发明名称 ANTI-WRINKLE COMPOSITION CONTAINING CAFFEOYLQUINIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS AN ACTIVE INGREDIENT
摘要 PURPOSE: A composition containing caffeoyl quinic acid derivatives and pharmaceutically acceptable salt thereof is provided to effectively suppress elastase activity of human neutrophil and to ensure anti-wrinkling. CONSTITUTION: A composition contains caffeoyl quinic acid derivatives and pharmaceutically acceptable salt thereof as an active ingredient. The composition is derived from one selected from the group consisting of (1S,3R,4R,5R)-3,4-bis((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)-1,5 dihydroxycyclohexane carboxylic acid, (1S,3R,4R,5R)-methyl-3,4-bis((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)-1,5-dihydroxycyclohexanecarboxylate, (1R,3R,4S,5R)-methyl-4,5-bis((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)-1,5-dihydroxycyclohexanecarboxylate, (1S,3R,4S,5R)-3,5-bis((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)-1,4-dihydroxycyclohexanecarboxylic acid, and (1S,3R,4S,5R)-methyl-3,5-bis((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)-1,4-dihydroxycyclohexanecarboxylate.
申请公布号 KR20110043195(A) 申请公布日期 2011.04.27
申请号 KR20090100207 申请日期 2009.10.21
申请人 HANKOOK PHARM. CO., INC. 发明人 YOO, ICK DONG;XU GUANGHUA;YOO, JAE KUK;HAN, SANG WOOCK
分类号 A61K31/192;A61K8/36;A61K31/216;A61P17/18 主分类号 A61K31/192
代理机构 代理人
主权项
地址